Ponatinix (Ponatinib) 45 MG – 30 TABLETS

$685.00

Ponatinib (Ponatinix) is a prescription medication which is a kinase inhibitor indicated for the treatment:

  • Adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.
  • Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.
whatsapp_qr
Whatsapp +8801922101029